Skip to content
value.today

Spiral Therapeutics Inc

🇺🇸 Brisbane, California, USAHealth CareFounded 2016
Total raised
$46 M
3 rounds on record
Latest round
$27 M
Sep 2025
First round on record
Dec 2018
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Spiral Therapeutics Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2025$27 MNo. 3$10 to $50 million

Spiral Therapeutics Inc: Raise no. 3, Sep 2025

Investors in this round

34 investors had bought by the notice of Apr 16, 2026: 34 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$27 M of $27 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Eugene De Juan · Executive Officer, Director
  • Hugo Peris · Executive Officer, Director
  • Angela Macfarlane · Director
  • Anthony Adamis · Director
  • Diamantis Xylas · Director
  • Frederic Guerard · Director
  • Guy Jean Savoir Garcia · Director
  • Jean-Frederic Paulsen · Director
  • Warren Thaler · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total Offering Amount includes conversion of outstanding indebtedness in the amount of $12,089,841.65.”

Signed by Hugo Peris, President and CEO. Newest notice filed Apr 16, 2026. Read the notice at the SEC.

equitySEC
Oct 2022$11 MNo. 2$10 to $50 million

Spiral Therapeutics Inc: Raise no. 2, Oct 2022

Investors in this round

48 investors had bought by the notice of Feb 7, 2023: 48 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $11 M offered
Smallest investment taken
no minimum stated
What was sold
equity, other: (i)Sale/issue of Ser A-4 Pref Stk, (ii)Ser A-5 Pref Stk, (iii)warrants to purchase Ser A-5 Pref Stk, (iv)Ser A-5 Pref Stk issuable upon exercise of the warrants, and (v)Common Stk issuable upon conver
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Hugo Peris · Executive Officer, Director
  • Angela Macfarlane · Director
  • Anthony Adamis · Director
  • Diamantis Xylas · Director
  • Eugene De Juan · Director
  • Guy Jean Savoir Garcia · Director
  • Guy P. Nohra · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total Offering Amount includes (i) conversion of outstanding indebtedness in the amount of $5,757,258 and (ii) future exercise prices of the Series A-5 Preferred Stock warrants in the aggregate amount of $2,647,718.”
  • On the use of proceeds: “Proceeds will be used for general corporate purposes including, but not limited to, executive salaries.”

Signed by Hugo Peris, President and CEO. Newest notice filed Feb 7, 2023 (1 amendment). Read the notice at the SEC.

equitySEC
Dec 2018$8 MNo. 1$2 to $10 million

Spiral Therapeutics Inc: Raise no. 1, Dec 2018

Investors in this round

38 investors had bought by the notice of Dec 19, 2018: 38 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $13 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Hugo Peris · Executive Officer, Director
  • Eugene de Juan · Director
  • Guy Jean Savoir Garcia · Director
  • Guy Nohra · Director
  • Lawrence Fritz · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Series A-1, Series A-2 and Series A-3 Preferred Stock; Common Stock issuable upon conversion. Offering amounts include conversion of outstanding convertible promissory notes.”

Signed by Hugo Peris, President and CEO. Newest notice filed Dec 19, 2018. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Spiral Therapeutics Inc chose not to state its revenue in its newest notice of a funding round (Apr 2026).

    SEC Form D · Apr 2026

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Apr 2026

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Spiral Therapeutics Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Spiral Therapeutics Inc
NameRoleNamed in
Eugene De JuanExecutive officerApr 2026
Hugo PerisExecutive officerApr 2026
Angela MacfarlaneDirectorApr 2026
Anthony AdamisDirectorApr 2026
Diamantis XylasDirectorApr 2026
Eugene De JuanDirectorApr 2026
Frederic GuerardDirectorApr 2026
Guy Jean Savoir GarciaDirectorApr 2026
Hugo PerisDirectorApr 2026
Jean-Frederic PaulsenDirectorApr 2026
Warren ThalerDirectorApr 2026
Guy P. NohraDirectorFeb 2023
Eugene de JuanDirectorDec 2018
Guy NohraDirectorDec 2018
Lawrence FritzDirectorDec 2018